Rapid infectious disease test MPR2019-D02

COVID-19proteinvirus

Product Advantages: 1. Coronavirus universal (N) gene detection + synchronous detection of key mutation sites can simultaneously achieve new coronavirus infection screening and mutant identification. 2. High detection sensitivity, up to 500copies/mL; for composite infected persons,it can detect variant strains as low as 0.1% to 0.01%. 3. Strong specificity, no cross-reactions such as non-specific amplification among different mutations. 4. Compatible with Bioteke rapid nucleic acid extraction technology, nucleic acid-free extraction technology and rapid fluorescence quantitative PCR instrument, and the detection results can be obtained within 45 minutes. Novel Coronavirus 2019-nCoV + S Mutant Nucleic Acid Detection Kit Model - Detection of mutation sites - Mutant MPR2019-D01 - N501Y + HV69-70del - Alpha (B.1.1. 7) - MPR2019-D02 - E484K + K417N - Beta (B.1.351) - MPR2019-D03 - E484K + K417T - Gamma (P.1) - MPR2019-D04 - L452R + E484Q + P681R - Delta (B.1.617)